Sign Up to like & get
recommendations!
0
Published in 2017 at "Revista Brasileira De Anestesiologia"
DOI: 10.1016/j.bjane.2017.04.001
Abstract: Abstract Background and objectives Reducing pain on injection of anesthetic drugs is of importance to every anesthesiologist. In this study we pursued to define if pretreatment by granisetron reduces the pain on injection of etomidate…
read more here.
Keywords:
etomidate;
study;
injection;
lidocaine ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2017.1342809
Abstract: ABSTRACT Introduction: Chemotherapy-induced nausea and vomiting (CINV) has a negative impact on the lives of subjects receiving chemotherapy. In 2009, the second generation 5-HT3-receptor antagonist, palonosetron, which is longer-acting than granisetron, was shown, as part…
read more here.
Keywords:
induced nausea;
cinv;
chemotherapy induced;
palonosetron ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Pakistan Journal of Medical Sciences"
DOI: 10.12669/pjms.38.7.5585
Abstract: Objectives: To evaluate and compare the Ondansetron and Granisetron in preventing spinal anaesthesia induced hemodynamic instability in obstetric patients Methods: The comparative analytical study was conducted at Combined Military Hospital, Rawalpindi, from September to October,…
read more here.
Keywords:
group;
ondansetron;
spinal anaesthesia;
value ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Die Pharmazie"
DOI: 10.1691/ph.2022.12000
Abstract: A triple antiemetic therapy combining aprepitant (APR) with conventional double antiemetic therapy, including 5-hydroxytryptamine 3 receptor antagonist (5-HT₃-RA) and dexamethasone (DEX), is recommended for preventing chemotherapy-induced nausea and vomiting induced by a carboplatin (CBDCA) regimen.…
read more here.
Keywords:
gda;
therapy;
group;
antiemetic therapy ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.1013284
Abstract: Background: In preclinical experiments, we demonstrated that the 5-HT3 receptor antagonist granisetron results in reduced inflammation and improved survival in septic mice. This randomized controlled trial was designed to assess the efficacy and safety of…
read more here.
Keywords:
day;
randomized controlled;
patients sepsis;
clinical trial ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "International journal of clinical pharmacology and therapeutics"
DOI: 10.5414/cp203327
Abstract: AIMS To examine the pharmacokinetics and safety of granisetron during transdermal delivery and oral administration to healthy Chinese male subjects. MATERIALS AND METHODS A single 34.3 mg/52 cm2 transdermal delivery patch of granisetron and the…
read more here.
Keywords:
pharmacokinetics safety;
granisetron;
healthy chinese;
subjects open ... See more keywords